Senzagen Ab Stock Shares Owned By Insiders
| SENZA Stock | SEK 6.95 0.15 2.11% |
SenzaGen AB fundamentals help investors to digest information that contributes to SenzaGen's financial success or failures. It also enables traders to predict the movement of SenzaGen Stock. The fundamental analysis module provides a way to measure SenzaGen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SenzaGen stock.
SenzaGen |
SenzaGen AB Company Shares Owned By Insiders Analysis
SenzaGen's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current SenzaGen Shares Owned By Insiders | 37.29 % |
Most of SenzaGen's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SenzaGen AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 37.291% of SenzaGen AB are shares owned by insiders. This is 145.66% higher than that of the Healthcare sector and 162.98% higher than that of the Biotechnology industry. The shares owned by insiders for all Sweden stocks is notably lower than that of the firm.
SenzaGen Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SenzaGen's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SenzaGen could also be used in its relative valuation, which is a method of valuing SenzaGen by comparing valuation metrics of similar companies.SenzaGen is currently under evaluation in shares owned by insiders category among its peers.
SenzaGen Fundamentals
| Return On Equity | -0.32 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (1.02) % | |||
| Operating Margin | (0.95) % | |||
| Current Valuation | 255.67 M | |||
| Shares Outstanding | 24.19 M | |||
| Shares Owned By Insiders | 37.29 % | |||
| Shares Owned By Institutions | 8.24 % | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 10.69 X | |||
| Revenue | 15.42 M | |||
| Gross Profit | 9.45 M | |||
| EBITDA | (27.08 M) | |||
| Net Income | (31.35 M) | |||
| Cash And Equivalents | 69.16 M | |||
| Cash Per Share | 3.63 X | |||
| Total Debt | 714 K | |||
| Current Ratio | 13.07 X | |||
| Book Value Per Share | 4.08 X | |||
| Cash Flow From Operations | (20.98 M) | |||
| Earnings Per Share | (1.35) X | |||
| Target Price | 16.0 | |||
| Number Of Employees | 29 | |||
| Beta | 0.47 | |||
| Market Capitalization | 308.55 M | |||
| Total Asset | 133.81 M | |||
| Net Asset | 133.81 M |
About SenzaGen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SenzaGen AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SenzaGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SenzaGen AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for SenzaGen Stock Analysis
When running SenzaGen's price analysis, check to measure SenzaGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenzaGen is operating at the current time. Most of SenzaGen's value examination focuses on studying past and present price action to predict the probability of SenzaGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenzaGen's price. Additionally, you may evaluate how the addition of SenzaGen to your portfolios can decrease your overall portfolio volatility.